ArticleFrontiers in pharmacology2017

Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study.

Shih-Wei Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.